The Need for Quantitative Biomedical Spectroscopic Imaging through Magnetic Resonance in Oncology beyond the Conventional Fourier-Based Signal Processing

Journal of Computational Methods in Sciences and Engineering

Volumn 3, Issue 4, 2003, Pages 535-561

  Belkić, Karen ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Advanced Signal Processing; Magnetic Resonance Spectroscopy; Oncology

Indexed keywords

BIOMEDICAL SIGNAL PROCESSING; DIAGNOSIS; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; ONCOLOGY; RESONANCE;

ADVANCED SIGNAL PROCESSING; CLINICAL PROBLEMS; DIAGNOSTIC MODALITY; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; MAGNETIC RESONANCE SPECTROSCOPIES (MRS); METABOLITE SPECTRA; MOLECULAR LEVELS; SPECTROSCOPIC IMAGING;

SIGNAL PROCESSING;

EID: 5044224000     PISSN: 14727978     EISSN: None     Source Type: Journal    
DOI: 10.3233/JCM-2003-3404     Document Type: Review

References (70)

1. J.K. Hennig, Fourier-based reconstruction techniques, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl. 1), 36 (2002).
2. Dž. Belkić, Fast Padé transform for magnetic resonance imaging and computerized tomography, Nucl. Instr. Meth. Phys. Res. A. 471, 165-169 (2001).
3. Dž. Belkić, Exact analytical expressions for any Lorentzian spectrum in the fast Padé transform (FPT), J. Com. Meth. Sci. Eng. 3, 109-186 (2003).
4. R. Katz-Brull, P.T. Lavin, R.E. Lenkinski, Clinical utility of proton magnetic resonance spec-troscopy in characterizing breast lesions, J. Natl. Cancer Inst. 94, 1197-1203 (2002).
5. 1H MR spectroscopy outside the brain, MagneticResonance Materials in Physics, Biology and Medicine 15 (Suppl. 1), 2 (2002).
6. J.R. Griffiths, A.R. Tate, F.A. Howe, M. Stubbs, as part of the Multi-Institutional Group on MRS Application to Cancer, Magnetic resonance spectroscopy of cancer - practicalities of multi-centre trials and early results in non-Hodgkin's lymphoma, Eur. J. Cancer 38, 2085-2093 (2002).
7. K. Belkić, Magnetic Resonant Spectroscopy and Spectroscopic Imaging: A Review of Basic Principles and Recent Achievements in Oncology, J. Comp. Meth. Sci. Eng. 3, 505-533 (2003).
8. S.W. Provencher, Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magnetic Resonance in Medicine 30, 672-679 (1993).
9. P.A. Bottomley, The trouble with spectroscopy papers, J. Magn. Reson. Imaging 2, 1-8 (1992).
10. D. Vigneron, A. Bollen, M. McDermott et al, Three-dimensional magnetic resonance spec-troscopic imaging of histologically confirmed brain tumors, Magnetic Resonance Imaging 19, 89-101 (2001).
11. B. Ciskowska-Lyson, L. Krolicki, A. Teska et al, Proton magnetic resonance spectroscopy investigations in brain metabolic changes after first doses of chemotherapy, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl. 1), 149 (2002).
12. D.C. Williamson, N.A. Thacker, S.R. Williams, Improved resolution metabolite maps from Multiple-Echo chemical shift imaging data, 20 th Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Rotterdam, The Netherlands, 2003.
13. C. Arús, Tumours and spectroscopy, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl. 1), 38 (2002).
14. 1H-MR spectra of human brain? Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl. 1), 128 (2002)
15. Dž. Belkić, Non-Fourier based reconstruction techniques, Magnetic Resonance Materials in Physics, Biology and Medicine 15 (Suppl. 1), 36-37 (2002)
16. Dž. Belkić, Padé-based Magnetic Resonance Spectroscopy (MRS), J. Com. Meth. Sci. Eng. 3, 563-729 (2003).
17. M.G. Swanson, D.B. Vigneron, T-K.C. Tran et al, Single-voxel over-sampled J-resolved spec-troscopy of in vivo human prostate tissue, Magn. Reson. Medicine 45, 973-980 (2001).
18. 1H MR spectroscopy for lateralization of temporal lobe epilepsy: a series of 82 patients, 20 th Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Rotterdam, The Netherlands, 2003.
19. S.K. Mukherji, S. Schiro, M. Castillo et al, Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies, Am. J. Neuroradiol. 18, 1057-1072 (1997).
20. 1H MR spectroscopy, J. Magn. Reson. Imaging 10, 159-164 (1999).
21. R. Katz-Brull, D. Seger, D. Rivenson-Segal, E. Rushkin, H. Degani, Metabolic markers of breast cancer, Cancer Research 62, 1966-1970 (2002).
22. W. Negendank, Studies of human tumours by MRS: A review, NMR Biomed. 5, 303-324 (1992).
23. Dž. Belkić, Strikingly stable convergence of the fast Padé transform: applications to Magnetic Resonance Spectroscopy (MRS), J. Comp. Meth. Sci. Eng. 3, 299-382 (2003).
24. Dž. Belkić, P.A. Dando, J. Main, H.S. Taylor, Three novel high-resolution nonlinear methods for fast signal processing, J. Chem. Phys. 113, 6542-6556 (2000).
25. D. Spielman, In vivo proton MR spectroscopy: basic principles and clinical applications, Section for Magnetic Resonance Technologists, 3, 19-37, (2000).
26. K. Belkić, Magnetic Resonance Spectroscopic Imaging in Breast Cancer Detection: Possibilities Beyond The Conventional Theoretical Framework For Data Analysis, Nucl. Instr. Meth. Phys. Res. A. (in press, May 2004).
27. I.S. Gribbestad, B. Sitter, S. Lundgren, J. Krane, D. Axelson, Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy, Anticancer Res. 19, 1737-1746 (1999).
28. I.S. Gribbestad, H.E. Fjosne, O.A. Haugen et al, In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue, Anticancer Res.13, 1973-1980 (1993).
29. 1H NMR spectroscopy of the human brain at 7 T. Magn. Res. Med. 46, 451-456 (2001).
30. G.G. Hillman, J.A. Triest, M.L. Cher et al, Prospects of immunotherapy for the treatment of prostate carcinoma - a review, Cancer Detection and Prevention 23, 333-342 (1999).
31. S. Mocellin, C.R. Rossi, M. Lise, F.M. Marincola, Adjuvant immunotherapy for solid tumors: from promise to clinical applications, Cancer Immunol. Immunother. 51, 583-595 (2002).
32. J. Shetye, P. Ragnhammar, M. Liljefors et al, Immunophatology of metastases in patients with colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factor, Clinical Cancer Research 4, 1921-1929 (1998).
33. G. Riethmuller, E. Holz, G. Schlimok et al, Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial, J. Clin. Oncol. 16, 1788-1794 (1998).
34. R.J. Mayer, Gastrointestinal tract cancer; In: E. Braunwald, A.S. Fauci, D.L. Kasper et al, Harrison's Principles of Internal Medicine 15 th Edition, McGraw-Hill, New York, pp. 578-588, 2001.
35. K. Kinkel, Y. Lu, M. Both, R.S. Warren, R.F. Thoeni, Detection of hepatic metastases from cancers of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MR imaging, PET): a meta-analysis, Radiology 224, 748-756 (2002).
36. E.M. Rohren, E.K. Paulson, R Hagge et al, The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer, Clinical Nuclear Medicine 27, 550-555 (2002).
37. Dž. Belkić, Analytical continuation by numerical means in spectral analysis using the fast Padé transform (FPT), Nucl. Instr. Meth. Phys. Res. A. (in press, May 2004).
38. P.N. Schultz, M.L. Beck, C. Stava, R.V. Sellin, Cancer survivors' work-related issues, J. Am. Assoc. Occupational Health Nurses 50, 220-226 (2002).
39. B. Gardell, Work organization and human nature, The Swedish Work Environment Fund, Stockholm, 1987.
40. K. Belkić, The Occupational Stress Index: An Approach Derived from Cognitive Ergonomics and Brain Research for Clinical Practice, Cambridge International Science Publishing, Cambridge, England, 2003.
41. P. Landsbergis, The changing organization of work and the safety and health of working people: A commentary, J. Occup. Environ. Med. 45, 61-72 (2003).
42. S.K. Lutgendorf, E.L. Johnsen, B. Cooper et al, Vascular endothelial growth factor and social support in patients with ovarian carcinoma, Cancer 95, 808-815 (2002).
43. N. Kawakami, T. Tanigawa, S. Araki et al, Effects of job strain on helper-inducer (CD4+CD29+) and suppressor-inducer (CD4+CD45RA+) T cells in Japanese blue-collar workers, Psychother. Psychosom. 66, 192-198 (1997).
44. H.-O. Adami, D. Hunter, D. Trichopoulos, Textbook of Cancer Epidemiology, Oxford University Press, New York, 2002.
45. E.S. Schernhammer, F. Laden, F.E. Speizer et al, Rotating night shifts and risk of breast cancer in the women participating in the nurses' health study, J. Natl. Cancer Inst. 93, 1563-1568 (2001).
46. E.S. Schernhammer, F. Laden, F.E. Speizer et al, Night-shift work and risk of colorectal cancer in the nurses' health study, J. Natl. Cancer Inst. 95, 825-828 (2003).
47. A.J. van Loon, M. Tijhuis, P.G. Surtees et al, Lifestyle risk factors for cancer: the relationship with psychosocial work environment, Int. J. Epidemiology 29, 785-792 (2000).
48. P.L. Schnall, K. Belkić, P.A. Landsbergis, D. Baker, The Workplace and Cardiovascular Disease, Occupational Medicine: State of the Art Reviews 15 1-334 (2000).
49. K. Belkić, Return to healthy work for patients who have been treated for cancer: a proactive clinical perspective informed by occupational health psychology. In: S. Giga, P. Plaxman, J. Houdmont, M. Ertel, European Academy of Occupational Health Psychology Conference Proceedings Series, ISBN: 0-9539936-3-9, ISSN 1473-0200, I-WHO Publications, Nottingham, England, p. 25, 2003.
50. J. Fisher, K. Belkić, A public health approach in clinical practice, Occupational Medicine: State of the Art Review. The Workplace and Cardiovascular Disease 15, 245-253 (2000).
51. American Cancer Society, Cancer Facts and Figures 2003 http://www.cancer.org/downloads/STT/Cancer.
52. F.D. Gilliland, W.C. Hunt, C.R. Key, Trends in the survival of American Indian, Hispanic and non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994, Cancer 82, 1769-1783 (1998).
53. L. Nyström, I. Andersson, N. Bjurstam et al, Long-term effects of mammography screening: updated overview of the Swedish randomised trials, Lancet 359, 909-919 (2002).
54. K.A. Phillips, K. Kerlikowske, L.C. Baker et al, Factors associated with women's adherence to mammography screening guidelines, Health Services Research 33, 29-53 (1998).
55. L. Terán, Compliance with Mammography Screening Guidelines among Latinas: An Exploratory Study, Doctoral Dissertation, University of Southern California School of Medicine, Department of Preventive Medicine, 2003.
56. F.D. Gilliland, R.D. Rosenberg, W.C. Hunt et al, Patterns of mammography use among Hispanic, American Indian, and non-Hispanic White women in New Mexico, 1994-1997, Am. J. Epidemiol. 152, 432-437, (2000).
57. A.E. Maxwell, R. Bastani, U.S. Warda, Misconceptions and mammography use among Filipino- and Korean-American women, Ethnicity and Disease 8, 377-384 (1998).
58. R. Bastani, A.C. Marcus, A. Hollatz-Brown, Screening mammography rates and barriers to use: a Los Angeles County survey, Preventive Medicine 20, 350-363 (1991).
59. P.M. Beemsterboer, P.G. Warmerdam, R. Boer, H.J. de Koning, Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J. Med. Screen. 5, 81-87 (1998).
60. D.J. Brenner, S.G. Sawant, M.P. Hande, R.C. Miller et al, Routine screening mammography: how important is the radiation-risk side of the benefit-risk equation? Int. J. Radiat. Biol. 78, 1065-1067 (2002).
61. K. Kerlikowske, V L Ernster, Women should be fully informed of the potential benefits and harms before screening mammography, West J. Med. 173, 313-314 (2000).
62. E. Prats, Symposium of breast imaging, Nucl. Med. Commun. 23, 607-608 (2002).
63. C. Rosé, J. Dose, N. Avril, Positron emission tomography for the diagnosis of breast cancer, Nucl. Med. Commun. 23, 613-618 (2002).
64. K. Wüthrich, The second decade - into the third millennium, Nature Structural Biology 5 (Suppl. S), 492-495 (1998).
65. D. Figeys, L.D. McBroom, M.F. Moran, Mass spectrometry for the study of protein-protein interactions, Methods 24, 230-239 (2001).
66. R.A. Gatenby, P.K. Maini, Cancer summed up, Nature 421, 321 (2003).
67. E.A. Sausville, D.L Longo, Principles of Cancer Treatment, In: E. Braunwald, A.S Fauci, D.L. Kasper, S.L Hauser, D.L. Longo, J.L. Jameson, Harrison's Principles of Internal Medicine McGraw-Hill, New York, pp. 530-547, 2001.
68. T.W. Cooley, J.W. Tukey, An algorithm for the machine calculation of complex Fourier series, Math. Computation 19, 297-301 (1965).
69. rd Edition, McGraw-Hill International Editions, Boston, 2000.
70. W.H. Press, S.A. Teukolsky, W.T. Vetterling and B.P. Flannery, Numerical Recipes, 2 nd edition, Cambridge University Press, Cambridge, 1992.